Skip to main content
    P

    ProQR Therapeutics BV (PRQR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.15
    -0.03 (-2.54%)

    Market Cap: $199.28M

    Last updated: Nov 17, 2026 at 4:20 PM ET

    ProQR Therapeutics BV (PRQR) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    ProQR Therapeutics BV (PRQR) has a market cap of $199.28M. Its share count is up 28.32% from a year earlier.

    Total Valuation

    Market Cap$199.28M
    Latest price (Nov 17, 2026)$1.15

    Key Dates

    The next earnings report is expected on Mar 10, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 10, 2027 (expected)
    Last Earnings DateAug 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 28.44% in the quarter ended Sep 30, 2026 and grew 31.51% a year over 2 years.

    Shares Outstanding141.23M
    Shares Change (YoY)+28.32%
    Shares Change (QoQ)+28.44%
    Share Count Growth (2Y CAGR)+31.51%

    Valuation Ratios

    Sales and book value multiples are 7.0x and 2.4x. Its year-end P/S ranged from 10.7x to 715.8x from 2016 to 2025.

    P/S Ratio7.0x
    P/B Ratio2.4x

    Valuation history and multiples

    Price Statistics

    The stock is down 47.00% over 52 weeks and trades 25.32% below its 50-day average.

    Beta (1Y)1.88
    52-Week Change-47.00%
    1-Month Change-12.21%
    3-Month Change-48.20%
    6-Month Change-19.58%
    5-Year Change-81.99%
    10-Year Change-73.27%
    Total Return (1Y)-47.00%
    Total Return (3Y CAGR)-7.86%
    Total Return (5Y CAGR)-31.74%
    Return vs SPY (1Y)-56.27%
    Max Drawdown (1Y)-53.06%
    Max Drawdown (3Y)-75.06%
    Sharpe Ratio (1Y)-0.78
    Correlation with SPY (1Y)0.34
    50-Day Average$1.54
    200-Day Average$1.67
    52-Week Range$1.17 to $2.48
    RSI (14 Days)35.4
    Average Volume (20 Days)790.61K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 3.21x current liabilities.

    Current Ratio3.21x
    Quick Ratio3.21x

    Returns and Efficiency

    Return on Assets (ROA)-43.00%
    ROE (5Y Average)-59.72%
    ROA (5Y Average)-25.15%
    ROIC (5Y Average)-47.82%
    Receivables Turnover7.23x

    Scores

    PRQR has an Altman Z-Score of 1.41, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Altman Z-Score1.41
    Altman Z ZoneDistress
    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Growth

    Revenue grew 61.99% a year over 3 years.

    Revenue Growth (3Y CAGR)+61.99%
    Revenue Growth (5Y CAGR)+71.53%

    Revenue and profit by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About PRQR

    What is PRQR's market cap?

    ProQR Therapeutics BV has a market cap of $199.28M.

    How many shares of PRQR are outstanding?

    ProQR Therapeutics BV has 141.23M shares outstanding. The count is up 28.32% from a year earlier.

    Does PRQR pay a dividend?

    No. ProQR Therapeutics BV does not pay a dividend.